ASSOCIATE DIRECTOR/DIRECTOR, FP&A

About Artiva :

Artiva is clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers.

Artiva's lead product candidate, AlloNK, is a non-genetically modified, off-the-shelf, allogeneic, cryopreserved NK cell therapy designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell depletion and to be administered in the community setting.

Unlike CAR-T and any genetically modified cell therapy, AlloNK is a non-genetically modified NK cell therapy candidate and has not shown any secondary malignancies in our clinical trials, which is a benefit in an autoimmunity setting.

Using the company's proprietary cell therapy manufacturing platform, Artiva can generate thousands of doses of cryopreserved, infusion-ready AlloNK cells from a single cord blood unit.

The FDA has granted Fast Track designation to AlloNK in combination with rituximab or obinutuzumab for the treatment of class III or IV lupus nephritis, and AlloNK in combination with rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma of B-cell origin (B-NHL).

AlloNK, is currently being evaluated in combination with B-cell targeted mAbs in

patients with autoimmune diseases and cancers, such as lupus nephritis, SLE, rheumatoid arthritis, pemphigus vulgaris, the ANCA-associated vasculitis subtypes GPA / MPA, and B-NHL.

In addition, we are also pursuing AlloNK and our CAR-NK product candidates in multiple indications through collaborator-funded trials.

Artiva's cell therapy manufacturing platform incorporates cell expansion and activation technology developed by Artiva's strategic partner, GC Cell Corporation, a member of the GC family of companies, a leading healthcare company in Korea.

Artiva is headquartered in San Diego and backed by leading venture investors including 5AM Ventures, RA Capital Management and venBio Partners.

For more information, visit www.artivabio.com.

Job Summary :

The Associate Director / Director, FP&A is primarily responsible for managing the company's financial planning and reporting processes, providing finance partnering to senior leadership and all functional areas across the Company.

This role will oversee critical financial functions, including forecasting, budgeting, long-term planning, and financial modeling.

The incumbent will be instrumental in providing critical financial insights and supporting strategic decision-making across the organization.

Duties / Responsibilities :

• Lead the annual budget preparation process in collaboration with department heads to align with strategic objectives and financial targets.
• Create and manage templates for gathering budget inputs from multiple sources.
• Drive the financial planning cycle, including rolling forecasts, scenario planning, and performance monitoring.
• Prepare and present financial performance reports to senior management, highlighting key insights and actionable recommendations.
• Perform variance analysis to compare actual results against budgeted figures, identifying discrepancies and their causes.
• Act as a key business partner, providing strategic financial insights and recommendations to support decision-making and strategic initiatives.
• Evaluate the financial implications of strategic decisions, operational changes, and external partnerships, proposing mitigation strategies as necessary.
• Adhere to the monthly close calendar, ensuring deliverables meet public company expectations, and continuously refine processes for optimal timing, accuracy, and quality.
• Support evaluation, design, implementation, and maintenance of financial systems and system upgrades
• Support ad hoc analyses and special projects across the organization, providing timely and accurate financial insights.

Requirements :

• Bachelor's degree in Finance, Accounting, Economics, or a related field.
• CPA and / or MBA (a plus)
• Minimum of 7 years of experience in financial planning and analysis, with significant experience in the biotech or pharmaceutical industry.
• Experience working in a public company environment.
• Clinical trial forecasting experience, preferred.
• Advanced proficiency in financial modeling, forecasting, and analysis.
• Excellent communication and presentation skills, capable of conveying complex financial information to diverse audiences.
• Proven track record of effective cross-functional collaboration and strategic business partnering.
• Strategic thinker with a proactive and results-driven approach.
• High level of integrity, with a commitment to ethical financial practices.
• Flexible, adaptive, and solutions oriented.

Why you should apply :

We have a fantastic team and philosophy! We are passionate - we deeply care about our team, our science, and improving the lives of cancer patients.

We are tenacious - laser-focused on our mission and undeterred in our commitment to deliver life-saving medicines for cancer patients.

We are innovative - pushing into new frontiers for patient benefit. We are transparent - believers in flat, accessible, and open communication paths.

We are inclusive - committed to the diversity of our team and ensuring that all voices are heard.

In addition to a great culture, we offer :

A beautiful facility

An entrepreneurial, highly collaborative, and innovative environment

Comprehensive benefits, including :

• Medical, Dental, and Vision
• Group Life Insurance
• Long Term Disability (LTD)
• 401(k) Retirement Plan
• Employee Assistance Program (EAP)
• Flexible Spending Account (FSA)
• Paid Time Off (PTO)
• Company paid holidays, including the year-end holiday week
• Our recognition program, Bonus.ly, is where you can trade in points earned for things you want.

If all this speaks to you, come join us on our journey!

Artiva Biotherapeutics is an equal employment opportunity employer.

Base Salary : $185,000 - $230,000. Exact compensation may vary based on skills and experience.